Of note, the HDAC inhibitor Cambinol has been shown to inhibit TNF and IL-6 secretion in bone marrow-derived macrophages stimulated with LPS and was associated with greater survival in a murine lethal endotoxemia model and in response to Klebsiella pneumoniae challenge (51). Here, IL6 is linked to serum lipopolysaccharide activity.